Categories
Pharmaceutical

North America to Lead Gas Chromatography Market the in Terms of Revenue Growth, Reveals Fact.MR Study

A recent research by Fact.MR estimates the global demand for gas chromatography market to exhibit an above-average expansion through the forecast period 2017 to 2022. The global market for gas chromatography is expected to exceed US$ 3,500 Mn in revenues by 2022-end.

There has been a significant surge in adoption of gas chromatography among industrial sectors such as oil & gas, agriculture, food & beverage, and healthcare. Gas chromatography is also being adopted in research organizations, academic institutes, clinical toxicology, and environmental agencies. Combination of gas chromatography and mass spectrometry (GC-MS), has found its application in fire investigation, identifying unknown samples, environmental analysis, investigation of explosives, and detection of drugs.

Request a report sample to gain comprehensive insights at  https://www.factmr.com/connectus/sample?flag=S&rep_id=193

On the back of these applications, gas chromatography will witness a substantial rise in demand in the upcoming years. Various governments are making investments for the development of advanced chromatography technologies. In addition, a number of collaborations have been witnessed between research laboratories, and academic institutes since the recent past. Gas chromatography tests have become highly imperative for drug approvals. The aforementioned factors will augment growth of the global gas chromatography market over the forecast period.

Higher growth potential for the market is being observed in emerging countries, because of their rising GDP, along with increasing healthcare spending driven by the large population base. One of the major trends discerned in the global gas chromatography market is growth in adoption of the micro gas chromatographs. A number of companies are shifting their focus to utilization of small instruments, in order to save huge investments and space. Several benefits are offered by micro gas chromatographs such as lower energy consumption, short delays in receiving results, lower sample gas quantity required, increased reliability in operation, and process accuracy & precision. However, instruments of gas chromatography involve huge initial capital investments, with shortage of skilled professions for their operation. These factors might hamper the market growth.

6 Key Projections on Future of Global Gas Chromatography Market
  1. Auto-samplers, and accessories & consumables will emerge as the fastest-selling products in the market, with auto-samplers being more lucrative than the accessories & consumables, in terms of revenues.
  2. Gas chromatography instruments will remain the most lucrative product, with sales estimated to surpass US$ 1,600 Mn in revenues by 2022-end.
  3. Oil & gas industries will continue to be the largest end-users in the global gas chromatography market. In addition, revenues from pharmaceutical & biotechnology industries, and oil & gas industries will hold approximately two-third market share during 2017 to 2022.
  4. North America will retain its dominance in the global gas chromatography market, with sales exhibiting an impressive expansion through 2022. United States is becoming well known for its biopharmaceutical research, and the production of pharmaceutical drugs. Geriatric population in North America has been surging, which in turn is driving demand for medicines to treat various diseases. These factors will propel growth of the market in North America.
  5. Europe will continue to be the second largest market for gas chromatography throughout the forecast period.
  6. Key players listed in Fact.MR’s report on the global gas chromatography market include Danaher Corporation, Perkin Elmer Inc., LECO Corporation, Shimadzu Corporation, Restek Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., DANI Instruments S.p.A, and Agilent Technologies.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=193

North America’s Dominance in the Global Gas Chromatography Market will Remain Unchallenged through 2022

North America is projected to remain the largest market for gas chromatography, expanding at an impressive CAGR through 2022. In this region, the United States is well known for biopharmaceutical research, and production of pharmaceutical drugs.

The number of geriatric population in North America is witnessing a rise, thereby driving demand for different medicines for treatment of different diseases. These factors will drive growth of gas chromatography market in North America. Europe is expected to be the second most lucrative market for gas chromatography over the forecast period.

Accessories & consumables, and auto-samplers are expected to emerge as the fastest-selling products in the global gas chromatography market. Auto-samplers will remain more lucrative than accessories & consumables of gas chromatography, in terms of revenues.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/193/gas-chromatography-market
Press Release: https://www.factmr.com/media-release/183/gas-chromatography-market 
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Urology Devices Market to reflect a CAGR of 6.4% over the forecast period, 2021-2026

Prevalence of various urological disorders has led to an upsurge in adoption of the urology devices globally. In addition, growing geriatric population is also projected to impact the global market growth of urology devices positively. Fact.MR states that the global market of urology devices is further to reflect a CAGR of 6.4% over the forecast period, 2021-2026.

Request a report sample to gain comprehensive insights at  https://www.factmr.com/connectus/sample?flag=S&rep_id=352

Factors Fuelling Global Market Growth

Growth of the global urology devices market is mainly bound to various macro-economic and micro-economic factors. Prevalence of kidney diseases will continue to fuel demand for various invasive and minimally treatment procedures. Unhygienic habits developed due to fast-paced lifestyle has led to increasing prevalence of various urological disorders among people of various age groups. Unmanaged obesity, excessive smoking and chronic coughing and sneezing has led to growing prevalence of diseases such as stress incontinence globally.

Moreover, surge in instances of childbirth and prostate surgery is further expected to contribute towards the global market growth of urology devices significantly. As childbirth surgery weakens the sphincter in women, they are more prone to urological diseases such as stress incontinence. In men, growing prevalence of prostate cancer requires a prostate gland, which could weaken the sphincter. Prevalence of diseases such as stress incontinence is further to rev up adoption of the urology devices in the healthcare industry.

urology devices market

Growing incidence of kidney stone due to lack of water intake among old age people will also continue to fuel adoption of various urological diseases. Untreated kidney stone diseases can result in other healthcare issues such as vomiting, persistent need to urinate, fever owing to infections in urinary tract. As demand for minimally treatment remains high, the healthcare professionals are significantly adopting shock wave lithotripsy devices for accurate treatment of kidney stones. Bound to these factors, the global market of urology devices is projected to witness significant growth through 2026.

In addition, manufacturers in the healthcare industry are concentrating on developing medical devices that offer minimally treatment process. Integration of leading technological developments in the medical devices enables the healthcare professionals to speed up the treatment process of the patients. The healthcare professionals are mainly adopting ultrasound or x-ray technology to trace stones in the kidney and disintegrate the stones into smaller fragments for smooth passage.

Manufacturers are further focusing on integrating advanced technology in order to develop robot-assisted medical devices. Robot-assisted medical devices are mainly tailored for accurate treatment of particular urological disorders and offer surgical navigation in order to assist during the treatment process. Increasing demand for robot-assisted urology devices and minimally treatment procedures will continue to impact the global market growth of urology devices positively throughout the forecast period.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=352

Sales to Remain High for Kidney Diseases

Prevalence of various chronic kidney disorders is projected to fuel demand for urological disorders for dialysis treatment. In terms of revenue, the dialysis devices product type segment is projected to witness the highest growth, recording more than US$ 2,100 Mn by 2026-end. In contrary, the robotic systems product type segment is projected to reflect significant CAGR over the forecast period.

By 2017-end, the hospitals and clinics end use segment is projected to generate significant revenues, accounting for more than US$ 1,500 Mn. However, the dialysis centers end use segment is projected to reflect a healthy CAGR throughout 2026. Throughout the forecast period, the cancer and BPH diseases segment is projected to reflect the fastest growth in the global market. On the other hand, the kidney disease segment is projected to witness robust revenue growth, recording more than US$ 2,400 Mn by 2026-end.

Market Players

Major players in the global market of urology devices are Baxter International, Inc., Siemens AG, Stryker Corporation, Boston Scientific Corp, Cook Medical Inc., Olympus Corporation, Richard Wolf GmbH and KARL STORZ GmbH & Co. KG.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/352/urology-devices-market
Press Release: https://www.factmr.com/media-release/341/urology-devices-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Drug Discovery Services Market worth US$ 16,800.1 Million by 2026 – Exclusive Report by Fact.MR

Drug discovery services have undergone a drastic change with the advancements in modern molecular biology methods and advanced knowledge of human genome. Drug discovery is becoming more hypothesis-driven target-based approach. Pharmaceutical companies and regulatory bodies are contributing to the drug discovery. Major pharmaceutical companies are also focusing on developing the team of excellent scientists working in many therapeutic fields and technologies.

In the recent years, there has been an increase in a number of approvals for first-in-class drugs, this reflects the impact of advanced drug discovery technologies, and approaches. Drug discovery service providers are also focusing on sequencing of the human genome in order to open the way to genomics-based methods in drug discovery.  Innovation currently seen in the drug discovery methods is based on more information about targets, disease phenotypes, and compounds.

Request a report sample to gain comprehensive insights at  https://www.factmr.com/connectus/sample?flag=S&rep_id=375

The report compiled by Fact.MR expects the global drug discovery services market is to witness robust growth, registering CAGR of 8.9% during 2017-2026. By the end of 2026, the global drug discovery services market is projected to reach US$ 16,800.1 million revenue. Increasing prevalence of chronic diseases and new diseases is driving the drug discovery services. Also, new technologies supporting drug discovery methods and techniques are evolving at a significant phase. Following are insight on how the global drug discovery services market will perform in the near future.

global drug discovery services market

6 Key Insights on Global Drug Discovery Services Market

1- North America is likely to remain dominant in the global drug discovery services market throughout the forecast period 2017-2026. Presence of leading pharmaceutical companies in the region is one of the factors driving the growth of drug discovery services in North America.

2- Asia Pacific Excluding Japan (APEJ) is also anticipated to witness significant growth during 2017-2026. India and China are slowly becoming preferred locations for drug discovery outsourcing due to the technological capabilities developed. Fewer regulations and low manufacturing costs are also fueling the growth in APEJ region.

3- Hit-To-Lead identification is likely to be the most preferred process in the global drug discovery services market. By the end of 2026, hit-to-lead identification is projected to reach nearly US$ 7,000 million revenue.

4- By drug discovery service type, medicinal chemistry is likely to witness the significant growth. Towards the end of 2026, medicinal chemistry is projected to surpass US$ 6,000 million revenue.

Request More Information about Report Methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=375

5- Small molecules are anticipated to be the largest drug type in the global drug discovery service market. Small molecules are projected to create an incremental opportunity of more than US$ 5,800 million between 2017 and 2026.

6- On the basis of therapeutic area, highest growth is expected to be seen in oncology. Oncology is projected to reach nearly US$ 7,000 million revenue towards the end of 2026.

The report offers a profile of some prominent players in the global drug discovery services market, which will stay active through 2026. The leading companies are Thermo Fisher Scientific, Inc., Merck Millipore, GE Healthcare, Albany Molecular Research, Inc. (AMRI), Charles River Laboratories International, Evotec, Pharmaceutical Product Development, LLC. (Ppd), Covance, Jubilant Biosys, Genscript Biotech Corporation, Aurigene Discovery Technologies, Wuxi Apptec, and Syngene.

Explore Fact.MR’s Coverage on the Healthcare Domain

Microcirculation Microscope Market: A recent study by Fact.MR on the Microcirculation Microscope market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Scanning Probe Microscopes Market: A detailed assessment of Scanning Probe Microscopes market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Microscopy Devices Market: Fact.MR delivers a detailed analysis on global Microscopy Devices market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/375/drug-discovery-services-market
Press Release: https://www.factmr.com/media-release/364/drug-discovery-services-market
Follow Us: LinkedIn | Twitter

Categories
Pharmaceutical

Worldwide Sales of Medical Holographic Displays is Projected to Reach a Value Pool US$ 3.5 Bn by 2026

The Demand for medical holography is set to record impressive growth, expanding at a whopping CAGR of 34.0% during the forecast period (2020-2026).

The high adoption of holographic devices for diagnosing chronic conditions such as cardiovascular diseases and cancer, rising financial impetus from government and private organizations and a surging geriatric population pool having chronic conditions are attributed as important growth levers.

Researchers have also advocated that medical holography procedures can be effectively exploited to diagnose COVID-19 infections among asymptomatic patients. These tests are expected to provide greater accuracy over the standard RT-PCR tests. Further research is still underway in order to ascertain the viability of such tests.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4798

“Increased demand for technological advancements in imaging techniques is anticipated to leverage the market for medical holography in the forecast period. Key manufacturers are taking advantage of this fact and concentrating on broad basing their product portfolio,” concludes a Fact.MR analyst.

global medical holography market share forecast by application

Global Medical Holography Market: Segmentation

Product

  • Holographic Display
  • Holography Microscope
  • Holographic Prints
  • Holography Software

Application

  • Medical Imaging
  • Medical Education
  • Biomedical Research
  • Medical Holography Market: In-Depth Analysis on Competitive Landscape

End-User

  • Academic Centers
  • Pharmaceutical & Biotechnology Companies
  • Hospitals

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4798

global medical holography market size growth forecast

Key Takeaways of Medical Holography Market Study:

  • By product type, holographic displays are anticipated to dominate the market, capturing nearly 70% of the market share. Increasing demand for technologically enhanced devices is driving the growth of the holographic displays segment.
  • By application, biomedical research shall find the maximum application, attributed to increased applications in advanced fields such as clinical diagnostics and drug development. The segment is anticipated to capture over 60% of the medical holography market.
  • By end-user, pharmaceutical and biotechnology companies shall capture over half of the total market, due to increasing research and development being undertaken to develop advanced technologies by important market players.
  • By region, North America and Europe are anticipated to lead the medical holography market, expanding at CAGRs of 35.5% and 34.0% respectively. Increasing research and development to introduce technological advancements as well as applications in diagnosing chronic conditions are anticipated to drive market growth in both regions.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4798

Following Questions Answers Covered in the Report are:

  • How will the global Medical Holography Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Medical Holography Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Medical Holography Market?
  • How will these strategies influence the market growth and competition?

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/renal-artery-stenosis-treatment-demand-driven-by-rising-prevalence-of-atherosclerosis-says-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value ChainMedical Holography Market: Competitive Landscape:The medical holography market consists of the following market players: RealView Imaging Ltd., EchoPixel Inc., Integraf LLC, Koninklijke Philips N.V, Holoxica Ltd., HoloTech Switzerland AG, EON Reality, Inc., Lyncee Tec SA, Nanolive SA and zSpace, Inc. Out of these, the dominant market players are RealView Imaging Ltd., Koninklijke Philips N.V. and Holoxica Ltd. These players focus primarily on technological developments in order to launch new products in the market, thereby consolidating their foothold. The products offered by the dominant players include HOLOSCOPE-i Holographic Augmented Reality Medical System (RealView Imaging), the Philips interventional X-ray and ultrasound systems (Koninklijke Philips N.V) and the Interactive Holographic 3D display (Holoxica Ltd.).

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Joint Reconstruction Is Set to Expand Modestly, Registering a Moderate CAGR of 4.0% By 2026

The global demand for orthopedic devices is set to expand modestly, registering a moderate CAGR of 4.0% throughout the forecast period (2020-2026).

A rapidly expanding geriatric population pool as well as increasing incidence rates of accidents and sports injuries are major factors contributing to the growth of the global orthopedic devices market. Moreover, technological advancements such as minimally invasive surgeries, artificial intelligence, 3D-bioprinting and tissue engineering, custom-made implants and development of variable axis screw systems are anticipated to provide a significant boost to the market.

However, the coronavirus pandemic is anticipated to limit growth prospects, with patients delaying elective surgical procedures in favor of treatment for COVID-19 infected patients. However, with social distancing measures being relaxed, the market is expected to witness a gradual resurgence, attributed to the restoration of production and manufacturing capacities of key industrial players, thus ameliorating the demand-supply gap.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4780

“Rising emphasis on technological innovations is anticipated to accelerate the growth of the global orthopedic devices market. Key manufacturers are exploiting this knowledge to develop new pipeline products,” infers a Fact.MR analyst.

global orthopedic devices market 02

Global Orthopedic Devices Market: Segmentation

Product

  • Joint Reconstruction:
    • Hip Replacement:
    • Total Hip Replacement Implant
    • Partial Hip Replacement Implant
    • Hip Resurfacing Implant
    • Revision Hip Replacement Implant
  • Knee Replacement:
    • Total Knee Replacement Implant
    • Partial Knee Replacement Implant
    • Revision Knee Replacement Implant
    • Elbow & Shoulder Replacement
    • Others
  • Spinal Devices:
    • Spinal Fusion Devices
    • Spinal Non-fusion Devices
  • Trauma Fixation:
    • Metal Plates & Screws
    • Pins/Wires
    • Nails and Rods
    • Others
  • Orthopedic Prosthetics:
    • Lower Extremity Orthopedic Prosthetics
    • Upper Extremity Orthopedic Prosthetics
    • Arthroscopy Devices
  • Orthopedic Braces and Support:
    • Upper Extremity Braces and Support
    • Low Extremity Braces and Support
  • Orthopedic Accessories:
    • Bone Cement
    • Casting System
    • Removal Systems
  • Others

End-User

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers
  • Others

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4780

Key Takeaways of Global Orthopedic Devices Market Study:

  • By product, the joint reconstruction segment shall dominate the market, acquiring a market share exceeding 30%. This is followed by the spinal devices segment, capturing 1/4th of the global orthopedic devices market. A large patient pool awaiting joint replacements and technological advancements in neurological surgeries are key growth drivers.
  • By end-user, orthopedic clinics are expected to gain significant traction. The segment is poised to expand 1.3x in the forecast period. However, the hospitals segment shall continue its dominance, capturing nearly half of the global orthopedic devices market.
  • By region, North America is expected to dominate the global orthopedic devices market, while Asia-Pacific shall expand the fastest. Growth in demand for orthopedic surgeries has attracted key market players to establish their businesses in North America while rising per capita healthcare expenditure is stimulating market growth in Asia-Pacific.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4780

Following Questions Answers Covered in the Report are:

  • How will the global Orthopedic Devices Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Orthopedic Devices Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Orthopedic Devices Market?
  • How will these strategies influence the market growth and competition?

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –https://www.biospace.com/article/increasing-r-and-d-and-improved-healthcare-spending-are-key-factors-pushing-development-of-waldenstrom-macroglobulinemia-market-growth-states-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Robust Product Portfolio, Key to Market Players’ Strong Presence:

The global orthopedic devices market is consolidated, dominated by the following top four players: Zimmer Biomet, Johnson & Johnson, Stryker and Smith & Nephew. Collectively, these companies account for nearly 55% of the market share. Therefore, the degree of competition from new entrants is quite low. Innovations in 3D printing and personalization implants technology are anticipated to fuel the growth of emerging players in the hip implants sub-segment. Important players in the hip implants segment include Smith & Nephew, DJO Global, Inc., Wright Medical Group N.V., and Exactech, Inc.

In 2017, Zimmer Biomet Holdings dominated the hip implants sub-segment, with a strong brand image and robust product portfolio. Its products included the Taperloc Hip System, the Arcos Modular Hip System and the G7 Acetabular System. Likewise, Stryker has a robust product portfolio, offering devices in the craniomaxillofacial, foot & ankle, joint replacement, spine and trauma & extremities segments. Its brands are Allograft Bio Implants, Delta, Advanced Midface Distractor and MEDPOR TITAN 3D Orbital Floor to name a few.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Glaucoma Alpha Agonists Healthcare Industry Insights: Prostaglandins are Anticipated to Account for the Maximum Market Share

Rising prevalence of glaucoma and other visual impairments have led to an increase in the demand for therapeutic drugs to treat these conditions. Around one-tenth of the elderly population suffers from glaucoma, which is expected to increase with each passing year. Consequently, the demand for better therapy options for the treatment of glaucoma is expected to boost demand for therapeutics.

On the back of these factors, the global glaucoma therapeutics market shall witness a gradual growth, at a CAGR of 2.9% during the forecast period (2020-2026). Other generic drivers, such as a greater geriatric population pool, a rise in the diabetic population and higher healthcare spending and infrastructure shall boost market growth.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4775

“The glaucoma therapeutics market shows a positive growth trend. Its market is expected to be invigorated by continuous research and product development, especially in combination drugs. Leading market players have accordingly developed formulae which can assist in faster recovery of glaucoma patients,” concludes a Fact.MR analyst.

glaucoma therapeutics market 02

Global Glaucoma Therapeutics Market: Segmentation

Drug Class

  • Prostaglandins
  • Beta Blockers
  • Alpha Agonists
  • Carbonic Anhydrase Inhibitors
  • Combination Medications
  • Cholingerics

End-users

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4775

Key Takeaways of Global Glaucoma Therapeutics Market Study

  • Prostaglandins are anticipated to account for the maximum market share of the glaucoma therapeutics market. This is attributed to its increased adoption in first line glaucoma treatment. The drug reduces intraocular pressure (IOP) by increasing uveoscleral flow. Projections indicate a market share of more than two-fifth of the total glaucoma therapeutics market.
  • Combination medicines are becoming more prevalent for glaucoma treatment. Greater effectiveness of treatment over individual medications is a key growth driver for this segment. For example, the Rhopressa drug class, a combination formula developed by Aerie Pharmaceuticals, has been approved for usage in commercial glaucoma treatment. Projected CAGR for combination medicines is pegged at 4.7% during the forecast period.
  • Hospitals shall account for the majority of the share of glaucoma therapeutics between 2020 and 2026. Increasing number of patients coupled with the ability to provide optimum healthcare services are major growth drivers.
  • North America is set to remain a lucrative market for glaucoma therapeutics. Increased focus on research and development of therapeutic drugs and approvals of certain drug categories like Rhopressa are expected to leverage the region’s market share. Asia-Pacific is following close behind, with a projected CAGR of 3.2% during the forecast period. Introduction of new drugs like Travopost and Timolol are expected to invigorate Asia-Pacific’s market share.

Following Questions Answers Covered in the Report are:

  • How will the global Glaucoma Therapeutics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Glaucoma Therapeutics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Glaucoma Therapeutics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4775

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/emergence-of-pharma-tech-and-new-product-launches-is-driving-growth-of-global-analytical-gel-permeation-chromatography-market-notes-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Combination Drugs; a Growth Lever for Market Players

The global glaucoma therapeutics market consists of the following market players: Allergan plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., Santen Pharmaceuticals Co. Ltd., Valeant Pharmaceuticals, Inc. and Aerie Pharmaceuticals, Inc. Novartis AG’s Alcon division focuses on development of eye care products, such as Travatan, Simbrinza and Azarga. Allergan Plc., occupies the second position in the market, and include top selling brands like Lumigan, Alphagan, Ganfort and Combigan. More recently, the company also received an approval from the FDA to launch its DURYSTATM Biodegradable Sustained-Release Implant. This device is designed to reduce intraocular pressure in open-angle glaucoma or ocular hypertension patients.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Radioimmunoassay (RIA) Is Poised to Register a Positive Growth Trend, Expanding at a CAGR of 6.0% | Report Fact.MR

According to Fact.MR’s Study, As the number of chronic and infectious diseases compound, medical advancements have grown in equal proportion. The global Demand for immunoassays is poised to register a positive growth trend, expanding at a CAGR of 6.0% throughout the forecast period (2020-2026).

Medical practitioners are increasingly relying on analyzer technique such as enzyme-linked immunosorbent assay (ELISA), immunofluorescent assay (IFA) and chemiluminescence immunoassay (CLIA) to detect infectious pathogens.

The novel coronavirus pandemic is an area where the immunoassay market shows promising developments. Key players have been conducting extensive research with the onset of the disease to determine possible antibodies to counter the virus. For instance, in April 2020, Bio-Rad Corporation announced the introduction of a blood-based immunoassay kit for the identification of antibodies for coronavirus. Besides, diagnosis of autoimmune diseases has also found increased applications of immunoassay treatments.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4766

“The global immunoassay market is poised to register positive growth in the future, burgeoned by increasing adoption of testing against the backdrop of rising prevalence of chronic and infectious diseases. In addition, the coronavirus pandemic is anticipated to provide further stimulus to the immunoassay testing market,” concludes a Fact.MR analyst.

Key Takeaways of Global Immunoassay Market Study:

  • By technology, chemiluminescence immunoassay (CLIA) shall capture nearly half of the global immunoassay market during the forecast period, expanding at a CAGR of 6.6% across the forecast period. Following behind is the enzyme-linked immunosorbent assay (CLIA), accounting for more than 30% of the market.
  • By product, the consumables segment shall capture greater than 4/5th of the global immunoassay market. Wide usage of immunoassays in diagnosing infectious diseases and endocrine disorders is driving the consumables segment growth.
  • By application, both endocrinal disorders and infectious diseases segment shall expand at a CAGR of 6.5% each, capturing 17.1% and 29.3% market shares respectively. Widespread applications of endocrinal testing for several disorders shall leverage growth prospects for endocrinal disorders while the ongoing COVID-19 pandemic is leveraging the infectious diseases segment.
  • By end-user, hospitals are anticipated to capture the majority of the market share (~81%) while blood banks shall expand the fastest, at a CAGR of nearly 7.0%. Increasing number of immunoassay tests in hospital settings is anticipated to drive the hospitals segment while increased demand for blood transfusions for curing infectious diseases is anticipated to leverage the blood banks segment.
  • By region, North America shall remain the supreme leader, accounting for nearly two-fifths of the global immunoassay market. However, Asia-Pacific promises to offer lucrative opportunities, expanding at a CAGR of 7.0%. Mergers and acquisitions among leading manufacturers and burgeoning investments in the life sciences and healthcare industry are key growth determinants in both regions.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4766

Global Immunoassay Market: Segmentation

Technology

  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Enzyme Linked Fluorescence Assay (ELFA)
  • Radioimmunoassay (RIA)
  • Others

Product

  • Analyzer
  • Consumables

Application

  • Infectious Diseases
  • Endocrinology
  • Oncology
  • Cardiology
  • Orthopedics
  • Others

End-user

  • Hospitals & Diagnostic Laboratories
  • Blood Banks
  • Others (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Forensic Labs, etc.)

Following Questions Answers Covered in the Report are:

  • How will the global Immunoassay Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Immunoassay Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Immunoassay Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4766

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –https://www.biospace.com/article/increased-awareness-about-women-health-is-key-for-driving-global-conjugated-estrogen-market/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Global Immunoassay Market: Competition Structure:

The global immunoassay market is highly consolidated. The top four market players constitute more than half of the total market share. These players are: F. Hoffmann La-Roche Ltd. (Roche Holdings AG), Abbott Laboratories, Siemens Healthineers and Beckman Coulter, Inc. (Danaher).

These players have consolidated their operations by virtue of important collaborations to burgeon production of immunoassay kits. La-Roche, for instance, offers products such as the COBAS C 702 & E 602 Module, the COBAS 4000 & 6000 Analyzer series and Elecsys Assays.

Likewise, Abbott Laboratories offers biotin-free assays to prevent interference in testing and the resulting inaccuracies. Other prominent immunoassay players include DiaSorin S.p.A., Sysmex Corporation, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company and Merck KGaA.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Endoscopy Fluid Management Is Set to Expand In The Wake of Increasing Incidence of End-Stage Renal Diseases : Latest Report Fact.MR

Fluid management is an integral component of patient care. It entails regulation and maintenance of overall fluid levels within the body. Each patient’s individual fluid needs differ, making the process extremely delicate. Fluid Management has shown increased application among patients suffering from end-stage renal disease (ESRD), an adverse condition arising out of diabetes.

Since kidney function drops to only 10-15% in this stage, it becomes very important to manage the fluid build-up inside the blood. On the back of this trend, the global demand for fluid management is anticipated to register a moderate growth of 5.3% during the forecast period (2020-2025)

“The global fluid management market is set to expand in the wake of increasing incidence of end-stage renal diseases, an anomaly arising out of diabetes. Continuous research and development of next-generation infusion devices is an important approach by leading manufacturers to consolidate their presence in the market,” concludes a Fact.MR analyst.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4763

Key Takeaways of Global Fluid Management Market Study:

  • Infusion therapy is set to dominate the global fluid management market, capturing more than half of the total market share. Demand for intravenous fluid administration to dehydrated patients unresponsive to oral therapy is poised to steer the market forward.
  • The renal products segment is anticipated to catch up, expanding at a CAGR of 5.5%. Increasing number of kidney patients has augmented the need for dialysis procedures and devices such as renal disposables and ancillaries, saline solutions & concentrates and dialysis accessories. This is foreseen to bolster the segment’s growth.
  • By end-user, hospitals are anticipated to capture maximum market share, amounting for almost two-fifth. Rising cases of chronic kidney infections are pushing people to seek treatment, thus augmenting growth. The segment is projected to expand 1.3x throughout the forecast period.
  • North America shall remain the kingpin in the global fluid management market, attributed to rising prevalence of lifestyle diseases, launch of next-generation infusion devices and a burgeoning demand for smart pumps. The infusion therapy segment shall account for more than half of the North American fluid management market.
  • However, Asia-Pacific shows promising growth prospects. Prevalence of typhoid, malaria and cholera which requires continuous fluid administration, as well as rising cases of ESRD are projected to leverage the Asia-Pacific market. The region is anticipated to expand 1.5x, at a CAGR of 7.0% throughout the forecast period.
  • Fluid management is poised to find increased application during the COVID-19 pandemic. Provision of hemodynamic support and reduction in the incidence of pulmonary edema are two important applications of fluid management amongst COVID-19 patients.
  • Important market players are extensively engaged in providing top-of-the-line solutions to medical practitioners for coping with the pandemic. To this end, Baxter Healthcare is concentrating on ensuring a steady supply of its products. The company proactively manages inventory levels, stock levels in warehouses and transportation options.
  • Baxter is also providing financial support to multiple groups addressing patient needs. It does so through its Baxter International Foundation. Dialysis supplies are also being augmented in order to cater to renal disorder patients.
  • Stryker Corporation, another market player, has released its Emergency Relief Bed, a limited-release medical bed to support critical needs during the pandemic. The bed features a 30-degree head of bed angle to accommodate patients in respiratory distress. It also features low height and an attached IV pole.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4763

Global Fluid Management Market: Segmentation

  • Application
    • Urology
    • Cardiology
    • Orthopedic/Osteology
    • Neurology
    • Oncology
    • Gastroenterology
    • Others (Anesthesiology, Bronchology, Dentistry, Otology and Gynecology)
  • End-users
    • Hospitals
    • Clinics
    • Dialysis Centers
    • Home Care Settings
    • Others
  • Key Regions
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Following Questions Answers Covered in the Report are:

  • How will the global Fluid Management Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Fluid Management Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Fluid Management Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4763

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –https://www.biospace.com/article/facial-spasm-treatment-demand-augmented-by-growing-awareness-of-the-treatment-options-says-fact-mr

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Infusion Products to Act as Key Growth Levers for Market Players

The global fluid management market comprises of a number of key companies. Prominent manufacturers with established market presence in global fluid management market are Baxter, C.R. Bard, Inc., BD, Smith & Nephew, B. Braun Holding GmbH & Co. KG, Fresenius SE & Co. KGaA, Cardinal Health Inc., Stryker, Boston Scientific Corporation and Karl Storz GmbH.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Standalone Indirect Calorimeters to Soar with High Growth Observed in Asia Pacific Unveils Fact.MR

This particular market is one of the few to benefit from the COVID-19 pandemic. Hospitals have shown significant increase in the demand for indirect calorimeters, especially standalone calorimeters meant for critical care units. On the other hand, portable calorimeters have also seen a rise in demand from research institutes due to inclined interest in research & development by key players in this market space.

Backed by advancements in technologies of indirect calorimeters, the market is expected to witness tremendous growth due to the cost effectiveness and convenience factor of these products, especially portable indirect calorimeters. Indirect calorimeters have several applications in monitoring a patient’s metabolic activities, which further helps doctors provide effective treatment. Thus, wider application of indirect calorimeters coupled with increasing number of hospital admissions will favor the growth of the global indirect calorimeter market over the forecast timeframe, which is projected to expand at a CAGR of 4% through 2030.

To remain ‘ahead’ of your competitors, request for a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=5108

“Increased sales of portable indirect calorimeters will boost market revenue over the coming years,” says a Fact.MR analyst.

indirect calorimeter market competitive analysis

Key Takeaways from Indirect Calorimeter Market Study

  • Investments in advanced technologies of indirect calorimeters will act as an important driver, increase 1.5x value by 2025.
  • Hospitals are the leading end user segment, accounting for 30% share in the indirect calorimeter market, due to significant increase in demand.
  • North America is a dominant region in the market, and accounts for 40% of the total revenue share.
  • Regions such as Asia are predicted to see significant growth in the indirect calorimeter market, based on exponential increase in population and rising medical tourism in the region.
  • The market is moderately consolidated in nature, with key players being COSMED, MGC Diagnostics, and KORR medicals, having a cumulative share of approximately 40% in the market.

Speak To Research Analyst For Detailed Insights:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=5108

Indirect Calorimeter Market Segmentation

Fact.MR has studied the indirect calorimeter market with detailed segmentation on the basis of type, end user, and key regions.

Type

  • Standalone Indirect Calorimeters
  • Portable Indirect Calorimeters

End User

  • Hospitals (Critical Care Units)
  • Research Institutes
  • Diagnostic Centers
  • Others (Sports Centers)

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

For critical insights on this market, request for methodology here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5108

Approval of Latest Indirect Calorimeters to Boost Market Revenues

COSMED, a leading player in the indirect calorimeter market, recently collaborated with the ICALIC Clinical Trial study group for Q-NRG+ indirect calorimeters, which got approved by the FDA, This collaboration has developed an accurate system that is simple to use, is able to solve all typical disadvantages of indirect calorimetry technology, and has a considerable improvement in functionality as compared to older and outdated products, thereby providing a significant boost to the growth of the market.

More Valuable Insights on Indirect Calorimeter Market

Fact.MR, in its new offering, presents an unbiased analysis of the global indirect calorimeter market, presenting historical demand data (2015-2019) and forecast statistics for the period of 2020-2030. The study divulges essential insights on the indirect calorimeter market on the basis of type (standalone indirect calorimeters, portable indirect calorimeters), end user (hospitals, critical care units, research institutes, diagnostic centres, sport institutes), and major regions of the world (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).

Key Prominent Players

  • Cosmed S.R.L
  • MGC Diagnostics
  • Microlife USA
  • KORR Medical Technologies
  • Maastricht Instruments BV
  • Vyaire Medical
  • Parvo Medics
  • GE Healthcare

Explore Fact.MR’s Coverage on the Healthcare Domain

Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Will Japan’s Liquid-Based Fiducial Markers Market Exhibit Hegemony : Check Fact.MR’s Latest Study

Fiducial markers sales are anticipated to surpass 100 Mn by 2019, registering an upswing from 93.9 Mn in 2018, according to a Fact.MR study. As fiducial markers gain traction in parallel to rising incidences of various cancer forms affecting lung, prostate, abdomen and kidney, the growth potential of the market is set to witness a considerable rise. The escalating demand for fiducial markers can be accredited to,

  • Growing adoption of radiotherapy devices by oncologists
  • Surging demand for IGRT and SBRT procedures
  • Versatility of fiducial markers in effective diagnosis
  • Increasing rates of cancer across the globe

Click HERE To get a SAMPLE PDF (Including Full TOC, Table & Figures) at
https://www.factmr.com/connectus/sample?flag=S&rep_id=1026

“Cancer survivors are increasingly opting for radio therapy procedures, either for primary management or for symptom control. This rise in embracement of radiotherapy as an effective methodology for diagnosis and management of cancer is substantially spurring sales of fiducial markers”, Senior Analyst, Fact.MR

With the adoption of fiducial markers as a standard tool for image-guided radiotherapy, manufacturers are coming across huge demand. According to a report titled “Radiotherapy in Global Cancer Control” published by the Cancer Control Organization, availability of radiotherapy equipment varied from 8.6 machines per million people in high-income countries (as per the World Bank definition) to 1.6 per million in high-middle income, 0.71 in low-middle income countries, and 0.21 per million in low-income countries. This data reveals the growth scope for fiducial markers over the coming years.

fiducial markers market competition

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=1026

Key Takeaways from Fiducial Markers Market Study

  • Germany remains the leading country in the world’s largest market for fiducial – Europe
  • The United States will remain the epicenter of the world’s largest fiducial markers market – North America – with a share of more than 85% in the region.
  • China, Japan, Indonesia, and others to remain highly sought-after markets for suppliers.
  • High demand for pure gold fiducial markers to fuel sales.
  • Growing requirement of photon therapy to propel growth of fiducial manufacturers.
  • In terms of disease site, prostate cancer to emerge as a dominant segment.
  • Radiotherapy centers to lead market demand in terms of end user.

Segmentation by Category

Product

  • Polymer Based Markers
  • Metal Based Markers
  • Pure Gold Markers
  • Liquid Based Markers

Modality

  • Photon Therapy
  • Proton Therapy
  • Tomotherapy
  • Cyberknife

Disease Site

  • Head & Neck
  • Breast
  • Lung
  • Abdomen
  • Prostate
  • Kidney
  • Cervix or Other Gynaecologic Organs

End User

  • Hospitals
  • Cancer Research Institutes
  • Radiotherapy Centers

Region

  • North America
  • Latin America
  • Europe
  • Middle East and Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/1026

Rise in Cases of Cancer Fuelling Sales of Fiducial Markers

As fiducial markers are an integral part of radiation therapy for cancer patients, rise in cases of cancer is fuelling sales. As per a report published by The International Agency for Research on Cancer (IARC) in December 2020, globally, 1 in 5 people develop cancer during their lifetime, while the fatality rate is 1 in 8 for men and 1 in 11 for women. The report also stated that, more than 50 million people are living within 5 years of a past cancer diagnosis.

According to a report published by the World Health Organization (WHO) on 12th September 2018, cancer is the second-leading cause of death globally, and was responsible for an estimated 9.6 million deaths in 2018. While this data represents the high fatality rate of cancer, it also signifies huge demand for various medical devices and equipment for its diagnosis and treatment, of which, fiducial markers play a huge role.

For More Insights

https://www.newswire.co.kr/newsRead.php?no=922809

Who is Winning in this Space?

As key market players are investing more, competition is getting tougher gradually in the fiducial markers market space. In order to leverage new opportunities, key players are diversifying their products.

For instance,

  • Boston Scientific launched its new LumiCoil™ Platinum Fiducial Markers, which are designed for clear visibility in CT, X-ray, EUS, and others, in January 2018.
  • Stellar Medical launched its new range of fiducial markers, such as Stellar Gold Fiducial Markers, Soft Tissue Implantable Gold Fiducial Markers, and others, in 2019.
  • Eckert & Zieglar BEBIG
  • Innovative Oncology Solutions
  • Boston Scientific
  • IBA
  • Best Medical International, Inc.
  • IZI Medical Products
  • Carbon Medical Technologies
  • CIVCO
  • AlphaXRT
  • Nanovi A/S
  • Stellar Medical

Explore Fact.MR’s Coverage on the Healthcare Domain

Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com